Try our Advanced Search for more refined results
- Adv. Search & Platform Tools
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Rankings
- Data-Driven Lawyers
- Regional Powerhouses
- Law360's MVPs
- Glass Ceiling Report
- Global 20
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Site Menu
- Join the Law360 team
- Search legal jobs
- Learn more about Law360
- Read testimonials
- Contact Law360
- Sign up for our newsletters
- Site Map
- Help
We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close
June 6, 2017
KPH HEALTHCARE SERVICES, INC. v. ACTAVIS HOLDCO U.S., INC. et al
Case Number:
2:17-cv-02555
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 7, 2017
Mylan, Others Rigged Generic Drug Prices, Suits Say
Drugmakers have unlawfully colluded to prevent competition for a generic numbing ointment as well as treatments for gallbladder stones, seizures and eczema, consequently inflating prices paid by direct purchasers, according to four separate antitrust suits filed Tuesday as part of multidistrict litigation in Pennsylvania federal court.
Parties
To view the parties, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login